427 related articles for article (PubMed ID: 11279155)
41. Brain-derived neurotrophic factor-, epidermal growth factor-, or A-Raf-induced growth of HaCaT keratinocytes requires extracellular signal-regulated kinase.
Rössler OG; Thiel G
Am J Physiol Cell Physiol; 2004 May; 286(5):C1118-29. PubMed ID: 15075211
[TBL] [Abstract][Full Text] [Related]
42. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.
Kainulainen V; Sundvall M; Määttä JA; Santiestevan E; Klagsbrun M; Elenius K
J Biol Chem; 2000 Mar; 275(12):8641-9. PubMed ID: 10722704
[TBL] [Abstract][Full Text] [Related]
43. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
44. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.
Decker SJ; Ellis C; Pawson T; Velu T
J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964
[TBL] [Abstract][Full Text] [Related]
45. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.
Martín-Orozco RM; Almaraz-Pro C; Rodríguez-Ubreva FJ; Cortés MA; Ropero S; Colomer R; López-Ruiz P; Colás B
Neoplasia; 2007 Aug; 9(8):614-24. PubMed ID: 17898861
[TBL] [Abstract][Full Text] [Related]
46. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
Kim HH; Vijapurkar U; Hellyer NJ; Bravo D; Koland JG
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
[TBL] [Abstract][Full Text] [Related]
47. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
48. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
Holgado-Madruga M; Wong AJ
Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
[TBL] [Abstract][Full Text] [Related]
49. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
[TBL] [Abstract][Full Text] [Related]
50. Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells.
Reynolds CM; Eguchi S; Frank GD; Motley ED
Hypertension; 2002 Feb; 39(2 Pt 2):525-9. PubMed ID: 11882602
[TBL] [Abstract][Full Text] [Related]
51. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
52. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
[TBL] [Abstract][Full Text] [Related]
53. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
[TBL] [Abstract][Full Text] [Related]
54. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. II. Comparison of phorbol ester and sphingomyelinase-induced phosphorylation of ErbB2 and ErbB3.
Emkey R; Kahn CR
J Biol Chem; 1997 Dec; 272(49):31182-9. PubMed ID: 9388272
[TBL] [Abstract][Full Text] [Related]
55. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
Justman QA; Clinton GM
J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
[TBL] [Abstract][Full Text] [Related]
56. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
57. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
58. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes.
Glasgow WC; Hui R; Everhart AL; Jayawickreme SP; Angerman-Stewart J; Han BB; Eling TE
J Biol Chem; 1997 Aug; 272(31):19269-76. PubMed ID: 9235921
[TBL] [Abstract][Full Text] [Related]
59. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.
Soltoff SP; Carraway KL; Prigent SA; Gullick WG; Cantley LC
Mol Cell Biol; 1994 Jun; 14(6):3550-8. PubMed ID: 7515147
[TBL] [Abstract][Full Text] [Related]
60. Role of ErbB2 in Corneal Epithelial Wound Healing.
Xu KP; Riggs A; Ding Y; Yu FS
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4277-83. PubMed ID: 15557433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
